Apnimed hires Pfizer, Biohaven veteran as chief commercial officer
Apnimed named a new chief commercial officer on Monday, tapping Graham Goodrich, a veteran biopharma marketing executive, to start building out a team to commercialize its oral sleep apnea candidate now in Phase III studies.
Goodrich joins Apnimed from Pfizer, where he was VP, US migraine franchise lead, having joined from Biohaven after Pfizer bought the migraine portfolio. Before that, Goodrich spent more than 11 years at Boehringer Ingelheim, leading marketing for both its respiratory and diabetes portfolios at different times.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.